[In vitro antibacterial activity of cefoperazone]. 1983

Y Watanabe, and S Minami, and A Yotsuji, and H Araki, and T Yasuda, and I Saikawa

The in vitro antibacterial activities of cefoperazone (CPZ) against clinical isolates including various beta-lactamase-producing strains were studied and compared with those of cefotiam (CTM). CPZ had a broad spectrum against Gram-negative and Gram-positive bacteria. Especially, CPZ showed apparently more potent antibacterial activities than CTM against Enterobacter cloacae, Serratia marcescens, and Pseudomonas aeruginosa. However, CPZ was less active than CTM against Staphylococcus aureus and Proteus mirabilis. The stability and affinity of CPZ for various types of beta-lactamase were also studied. CPZ was more resistant to hydrolysis by typical cephalosporinase (CSase) and cefuroximase (CXase) than CTM, but was less stable to penicillinase (PCase). CPZ often showed higher affinity to beta-lactamases than CTM. The study for the inducer-activity revealed that CPZ hardly induced CSase production in E. cloacae and Proteus vulgaris while CTM highly induced in both strains. CPZ was more active against CSase-producers than CTM, especially against strains which inducibly produced the enzyme. It was speculated that this activity was responsible for the superior stability to CSase and low inducer-activity for CSase production.

UI MeSH Term Description Entries
D002438 Cefoperazone Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections. Cefobid,Cefoperazon,Cefoperazone Sodium,Cefoperazone Sodium Salt,Céfobis,T-1551,T1551,Salt, Cefoperazone Sodium,Sodium Salt, Cefoperazone,Sodium, Cefoperazone,T 1551
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases

Related Publications

Y Watanabe, and S Minami, and A Yotsuji, and H Araki, and T Yasuda, and I Saikawa
October 1995, Zhonghua nei ke za zhi,
Y Watanabe, and S Minami, and A Yotsuji, and H Araki, and T Yasuda, and I Saikawa
January 1980, Clinical therapeutics,
Y Watanabe, and S Minami, and A Yotsuji, and H Araki, and T Yasuda, and I Saikawa
August 1981, The Journal of antimicrobial chemotherapy,
Y Watanabe, and S Minami, and A Yotsuji, and H Araki, and T Yasuda, and I Saikawa
December 1979, Antimicrobial agents and chemotherapy,
Y Watanabe, and S Minami, and A Yotsuji, and H Araki, and T Yasuda, and I Saikawa
March 1983, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
Y Watanabe, and S Minami, and A Yotsuji, and H Araki, and T Yasuda, and I Saikawa
January 1991, Diagnostic microbiology and infectious disease,
Y Watanabe, and S Minami, and A Yotsuji, and H Araki, and T Yasuda, and I Saikawa
August 1994, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
Y Watanabe, and S Minami, and A Yotsuji, and H Araki, and T Yasuda, and I Saikawa
January 1983, Arzneimittel-Forschung,
Y Watanabe, and S Minami, and A Yotsuji, and H Araki, and T Yasuda, and I Saikawa
January 1990, Diagnostic microbiology and infectious disease,
Y Watanabe, and S Minami, and A Yotsuji, and H Araki, and T Yasuda, and I Saikawa
January 1981, Drugs,
Copied contents to your clipboard!